|
TCHP expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.49540437997121E-11 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.24579999649654E-08 |
| Normal-vs-Stage2 |
1.436860E-03 |
| Normal-vs-Stage3 |
4.45820047545453E-11 |
| Normal-vs-Stage4 |
1.66466840312296E-12 |
| Stage1-vs-Stage2 |
2.646200E-01 |
| Stage1-vs-Stage3 |
8.766400E-02 |
| Stage1-vs-Stage4 |
1.785530E-04 |
| Stage2-vs-Stage3 |
3.134000E-02 |
| Stage2-vs-Stage4 |
1.440050E-03 |
| Stage3-vs-Stage4 |
5.597800E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.93409790592159E-11 |
| Normal-vs-AfricanAmerican |
3.81469999999329E-06 |
| Normal-vs-Asian |
1.82531999999291E-05 |
| Caucasian-vs-AfricanAmerican |
7.391000E-01 |
| Caucasian-vs-Asian |
2.339000E-01 |
| AfricanAmerican-vs-Asian |
4.922200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.21960014204592E-10 |
| Normal-vs-Female |
7.44709960365242E-10 |
| Male-vs-Female |
4.762600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.8233973199151E-11 |
| Normal-vs-Age(41-60Yrs) |
8.53740000916758E-09 |
| Normal-vs-Age(61-80Yrs) |
5.01799712893103E-11 |
| Normal-vs-Age(81-100Yrs) |
1.613300E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.112400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.246600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.083800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.981000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.454400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.470000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.380000E-03 |
| Classical-VS-Follicular |
9.979900E-02 |
| Classical-VS-Other |
8.865600E-01 |
| Classical-VS-Normal |
5.29420951522752E-12 |
| Tall-VS-Follicular |
9.381400E-04 |
| Tall-VS-Other |
4.966800E-01 |
| Tall-VS-Normal |
8.65363336544078E-12 |
| Follicular-VS-Other |
5.554600E-01 |
| Follicular-VS-Normal |
5.577600E-04 |
| Other-VS-Normal |
8.941300E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.97350000008534E-07 |
| Normal-vs-N1 |
4.56301663120939E-13 |
| N0-vs-N1 |
3.641600E-04 |
|
|
